Morikawa, Naoto
The University of Texas MD Anderson Cancer Center
2 papers on CoChatORCID 0000-0002-4728-0965
Most cited papers
- Verified
Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer
Sen, T., Rodriguez, B. L., Chen, L., Corte, C. M. D., Morikawa, N., Fujimoto, J., Cristea, S., Nguyen, T., Diao, L., Li, L., et al. (2019) · Cancer Discovery
Cancer Immunotherapy and BiomarkersLung Cancer Research Studies
Cited by 902
- Verified
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations
Inoue, A., Suzuki, T., Fukuhara, T., Maemondo, M., Kimura, Y., Morikawa, N., Watanabe, H., Saijo, Y., & Nukiwa, T. (2006) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 509
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free